Chunghwa Chemical Synthesis & Biotech Co Ltd (1762.TW) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · Taiwan · ISIN TW0001762003
Chunghwa Chemical Synthesis & Biotech Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.35 bn TWD | 804.88 m TWD |
| Gross profit | 394.32 m TWD | -8.86 m TWD |
| Operating income | 6.34 m TWD | -319.54 m TWD |
| EBIT | 78.51 m TWD | -238.95 m TWD |
| Net income | 53.03 m TWD | -243.85 m TWD |
| Diluted EPS – continuing operations | 0.70 TWD | -4.39 TWD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Chunghwa Chemical Synthesis & Biotech Co Ltd
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacturing, sale, and wholesale of western medicine in Taiwan and internationally. The company offers biotechnology products, including Anidulafungin antifungal medication, Caspofungin Acetate antifungal medication, Dalbavancin Hydrochloride Bacterial Skin Infection Drug, Everolimus, immunosuppressant and anticancer drug), Midostaurin for treating acute myeloid leukemia, Pneumocandin B0 antifungal intermediate, Rapamycin, Rezafungin acetate antifungal medication, Semaglutide weight loss medication, and Tacrolimus immunosuppressant, as well as Mycophenolate Mofetil, Mycophenolate Mofetil HCl, and Mycophenolate Sodium immunosuppressive drugs. It also provides non-biotechnology products, such as Abaloparatide osteoporosis medication, Baricitinib rheumatoid arthritis medication, Brivaracetam antiepileptic drug, Difelikefalin Acetate Pruritus, Edoxaban Tosylate Monohydrate, Eltrombopag Olamine, Eslicarbazepine Actate, Ethyl Icosapentate, Lanreotide Acetateacromegaly), Ozanimod HCl medicine for multiple sclerosis, Ribociclib for breast cancer medication, Plecanatide chronic idiopathic constipation medication, Ribociclib breast cancer medication, Selumetinib Sulfate for neurofibromatosis, Setmelanotide Acetate genetic obesity drug, Sugammadex Sodium anesthesia recovery medication, Tofacitinib Citrate rheumatoid arthritis medication, Trandolapril antihypertensive medication, Trilaciclib Dihydrochloride bone marrow protectant, Tenapanor HCl medication for constipation-predominant irritable bowel syndrome and hyperphosphatemia in dialysis patients. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. and changed its name to Chunghwa Chemical Synthesis & Biotech Co., Ltd. in January 2003. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
More stocks
- S2W (488280.KQ)
- ZJK Industrial Co., Ltd (ZJK)
- EcoSynthetix Inc (ECO.TO)
- Malaysian Bulk Carriers Bhd (5077.KL)
- Stormtec (352090.KQ)
- Qing Song Health Co.,Ltd. (6931.TW)
- CKM Building Material (8930.TWO)
- Grong Sparebank (GRONG.OL)
- AB Science S.A (AB.PA)
- OZ VISION INC. (OZVN)
- GrowGeneration Corp. (GRWG)
- Kumho Electric (001210.KS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.